File Download
  Patent History
  • Application
    PC T/CN2015086745 2015-08-12
  • Publication
    WO 2016023491 2016-02-18
  Patent Family

Patent: BIOPHOSPHONATE COMPOUNDS AND GAMMA DELTA T CELL-MEDIATED THERAPY FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS

TitleBIOPHOSPHONATE COMPOUNDS AND GAMMA DELTA T CELL-MEDIATED THERAPY FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS
Priority Date2014-08-12 US 12/2036487P
Inventors
Issue Date2016
Citation
WO Published patent application WO 2016023491. World Intellectual Property Organization (WIPO), PatentScope, 2016 How to Cite?
AbstractAminobisphosphonate pamidronate (PAM) can control Epstein-Barr virus (EBV) associated disorders in humanized mice through a Vγ9Vδ2-T-cell dependent mechanism. This suggests a strong potential for a therapeutic approach using PAM to boost human Vγ9Vδ2-T-cell immunity against EBV associated disorders, such as the lymphoproliferative disease (LPD),posttransplant lymphoproliferative disorder (PLPD), Hodgkin's disease,Burkitt's lymphoma, and nasopharyngeal carcinoma (NPC).
Persistent Identifierhttp://hdl.handle.net/10722/225269
References

 

DC FieldValueLanguage
dc.date.accessioned2016-05-03T05:10:12Z-
dc.date.available2016-05-03T05:10:12Z-
dc.date.issued2016-
dc.identifier.citationWO Published patent application WO 2016023491. World Intellectual Property Organization (WIPO), PatentScope, 2016-
dc.identifier.urihttp://hdl.handle.net/10722/225269-
dc.description.abstractAminobisphosphonate pamidronate (PAM) can control Epstein-Barr virus (EBV) associated disorders in humanized mice through a Vγ9Vδ2-T-cell dependent mechanism. This suggests a strong potential for a therapeutic approach using PAM to boost human Vγ9Vδ2-T-cell immunity against EBV associated disorders, such as the lymphoproliferative disease (LPD),posttransplant lymphoproliferative disorder (PLPD), Hodgkin's disease,Burkitt's lymphoma, and nasopharyngeal carcinoma (NPC).-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleBIOPHOSPHONATE COMPOUNDS AND GAMMA DELTA T CELL-MEDIATED THERAPY FOR TREATING EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS-
dc.typePatent-
dc.identifier.authorityTU, WENWEI=rp00416-
dc.identifier.authorityLIU, YINPING=rp00269-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorTU, WENWEI-
dc.contributor.inventorLIU, YINPING-
dc.contributor.inventorXIANG, ZHENG-
patents.identifier.applicationPC T/CN2015086745-
patents.description.assignee UNIV HONG KONG [CN] -
patents.description.countryWorld Intellectual Property Organization (WIPO) -
patents.date.publication2016-02-18-
dc.relation.referencesCN 101926778 (A) 2010-12-29-
dc.relation.referencesXP 002588966-
patents.identifier.hkutechidPAED-2014-00536-2-
patents.date.application2015-08-12-
patents.date.priority2014-08-12 US 12/2036487P-
patents.description.ccwo-
patents.identifier.publicationWO 2016023491-
patents.relation.familyUS 2016045521 (A1) 2016-02-18-
patents.description.kindA1-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats